US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist

3.620
-0.025-0.69%

Close Apr 26 16:00 ET

3.620
0.0000.00%

Post 16:20 ET

197.79MMarket Cap-2701P/E (TTM)

Elevation Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

34.28%-56.18M

31.76%-12.18M

69.77%-13.36M

-46.50%-13.81M

-20.02%-16.83M

-183.37%-85.48M

-100.24%-17.85M

-459.00%-44.18M

-143.47%-9.43M

-47.98%-14.02M

Net income from continuing operations

51.93%-45.7M

58.52%-7.9M

72.61%-10.64M

49.26%-10.11M

1.25%-17.06M

-196.76%-95.08M

-97.90%-19.04M

-216.60%-38.84M

-293.87%-19.93M

-239.32%-17.28M

Depreciation and amortization

44.44%39K

0.00%10K

12.50%9K

100.00%10K

150.00%10K

50.00%27K

100.00%10K

166.67%8K

-16.67%5K

0.00%4K

Other non cash items

146.32%702K

10.78%185K

--180K

--172K

--165K

--285K

--167K

----

Change In working capital

-317.65%-13.69M

-1,380.84%-4.28M

43.76%-3.55M

-147.67%-4.61M

-148.25%-1.26M

2,122.61%6.29M

2,285.71%334K

-270.52%-6.31M

844.28%9.66M

158.52%2.61M

-Change in prepaid assets

-251.31%-2.14M

-215.89%-815K

-18.40%-2.74M

-48.95%512K

-6.15%901K

64.58%-610K

-348.08%-258K

-1.58%-2.32M

25.38%1M

376.66%960K

-Change in payables and accrued expense

-267.35%-11.55M

-684.97%-3.46M

79.78%-808K

-159.11%-5.12M

-231.09%-2.16M

244.14%6.9M

757.78%592K

-166.82%-4M

3,782.06%8.66M

140.09%1.65M

Cash from discontinued investing activities

Operating cash flow

34.28%-56.18M

31.76%-12.18M

69.77%-13.36M

-46.50%-13.81M

-20.02%-16.83M

-183.37%-85.48M

-100.24%-17.85M

-459.00%-44.18M

-143.47%-9.43M

-47.98%-14.02M

Investing cash flow

Cash flow from continuing investing activities

126.00%11.54M

-41.33%6.56M

-385.18%-38.12M

59.79%16.5M

133.56%26.6M

-44.4M

11.18M

13.37M

10.33M

-79.27M

Net PPE purchase and sale

--0

----

---86K

--0

----

Net investment purchase and sale

126.05%11.54M

-41.33%6.56M

-383.36%-38.12M

59.79%16.5M

133.56%26.6M

---44.31M

--11.18M

--13.45M

--10.33M

---79.27M

Cash from discontinued investing activities

Investing cash flow

126.00%11.54M

-41.33%6.56M

-385.18%-38.12M

59.79%16.5M

133.56%26.6M

---44.4M

--11.18M

--13.37M

--10.33M

---79.27M

Financing cash flow

Cash flow from continuing financing activities

62.55%47.98M

50.00%-2K

-99.91%27K

191,036.00%47.73M

1,036.84%216K

-69.59%29.51M

-4K

480.61%29.52M

-100.03%-25K

272.73%19K

Net issuance payments of debt

--0

----

--30M

--0

----

Net common stock issuance

132,897.14%46.48M

50.00%-2K

50.00%-3K

186,084.00%46.5M

---12K

-100.04%-35K

---4K

-100.12%-6K

---25K

--0

Proceeds from stock option exercised by employees

7,773.68%1.5M

--0

--30K

--1.24M

1,100.00%228K

--19K

--0

--19K

Net other financing activities

----

-4,172.73%-470K

--0

----

Cash from discontinued financing activities

Financing cash flow

62.55%47.98M

50.00%-2K

-99.91%27K

191,036.00%47.73M

1,036.84%216K

-69.59%29.51M

---4K

480.61%29.52M

-100.03%-25K

272.73%19K

Net cash flow

Beginning cash position

-68.61%45.92M

4.35%54.88M

97.33%106.33M

5.46%55.9M

-68.61%45.92M

84.24%146.28M

-66.11%52.59M

-65.90%53.88M

-24.18%53.01M

84.24%146.28M

Current changes in cash

103.33%3.34M

15.72%-5.62M

-3,878.89%-51.45M

5,669.22%50.42M

110.70%9.99M

-250.06%-100.37M

25.15%-6.67M

54.13%-1.29M

-99.01%874K

-883.09%-93.28M

End cash Position

7.27%49.26M

4.35%54.88M

97.33%106.33M

5.46%55.9M

-68.61%45.92M

-66.11%52.59M

-65.90%53.88M

-24.18%53.01M

Free cash flow

34.35%-56.18M

31.76%-12.18M

69.83%-13.36M

-46.50%-13.81M

-20.02%-16.83M

-183.65%-85.57M

-100.24%-17.85M

-460.08%-44.27M

-143.47%-9.43M

-47.98%-14.02M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	34.28%-56.18M	31.76%-12.18M	69.77%-13.36M	-46.50%-13.81M	-20.02%-16.83M	-183.37%-85.48M	-100.24%-17.85M	-459.00%-44.18M	-143.47%-9.43M	-47.98%-14.02M
Net income from continuing operations	51.93%-45.7M	58.52%-7.9M	72.61%-10.64M	49.26%-10.11M	1.25%-17.06M	-196.76%-95.08M	-97.90%-19.04M	-216.60%-38.84M	-293.87%-19.93M	-239.32%-17.28M
Depreciation and amortization	44.44%39K	0.00%10K	12.50%9K	100.00%10K	150.00%10K	50.00%27K	100.00%10K	166.67%8K	-16.67%5K	0.00%4K
Other non cash items	146.32%702K	10.78%185K	--180K	--172K	--165K	--285K	--167K	----	----	----
Change In working capital	-317.65%-13.69M	-1,380.84%-4.28M	43.76%-3.55M	-147.67%-4.61M	-148.25%-1.26M	2,122.61%6.29M	2,285.71%334K	-270.52%-6.31M	844.28%9.66M	158.52%2.61M
-Change in prepaid assets	-251.31%-2.14M	-215.89%-815K	-18.40%-2.74M	-48.95%512K	-6.15%901K	64.58%-610K	-348.08%-258K	-1.58%-2.32M	25.38%1M	376.66%960K
-Change in payables and accrued expense	-267.35%-11.55M	-684.97%-3.46M	79.78%-808K	-159.11%-5.12M	-231.09%-2.16M	244.14%6.9M	757.78%592K	-166.82%-4M	3,782.06%8.66M	140.09%1.65M
Cash from discontinued investing activities
Operating cash flow	34.28%-56.18M	31.76%-12.18M	69.77%-13.36M	-46.50%-13.81M	-20.02%-16.83M	-183.37%-85.48M	-100.24%-17.85M	-459.00%-44.18M	-143.47%-9.43M	-47.98%-14.02M
Investing cash flow
Cash flow from continuing investing activities	126.00%11.54M	-41.33%6.56M	-385.18%-38.12M	59.79%16.5M	133.56%26.6M	-44.4M	11.18M	13.37M	10.33M	-79.27M
Net PPE purchase and sale	--0	--0	----	----	----	---86K	--0	----	----	----
Net investment purchase and sale	126.05%11.54M	-41.33%6.56M	-383.36%-38.12M	59.79%16.5M	133.56%26.6M	---44.31M	--11.18M	--13.45M	--10.33M	---79.27M
Cash from discontinued investing activities
Investing cash flow	126.00%11.54M	-41.33%6.56M	-385.18%-38.12M	59.79%16.5M	133.56%26.6M	---44.4M	--11.18M	--13.37M	--10.33M	---79.27M
Financing cash flow
Cash flow from continuing financing activities	62.55%47.98M	50.00%-2K	-99.91%27K	191,036.00%47.73M	1,036.84%216K	-69.59%29.51M	-4K	480.61%29.52M	-100.03%-25K	272.73%19K
Net issuance payments of debt	--0	--0	----	----	----	--30M	--0	----	----	----
Net common stock issuance	132,897.14%46.48M	50.00%-2K	50.00%-3K	186,084.00%46.5M	---12K	-100.04%-35K	---4K	-100.12%-6K	---25K	--0
Proceeds from stock option exercised by employees	7,773.68%1.5M	--0	--30K	--1.24M	1,100.00%228K	--19K	--0	--0	--0	--19K
Net other financing activities	----	----	----	----	----	-4,172.73%-470K	--0	----	----	----
Cash from discontinued financing activities
Financing cash flow	62.55%47.98M	50.00%-2K	-99.91%27K	191,036.00%47.73M	1,036.84%216K	-69.59%29.51M	---4K	480.61%29.52M	-100.03%-25K	272.73%19K
Net cash flow
Beginning cash position	-68.61%45.92M	4.35%54.88M	97.33%106.33M	5.46%55.9M	-68.61%45.92M	84.24%146.28M	-66.11%52.59M	-65.90%53.88M	-24.18%53.01M	84.24%146.28M
Current changes in cash	103.33%3.34M	15.72%-5.62M	-3,878.89%-51.45M	5,669.22%50.42M	110.70%9.99M	-250.06%-100.37M	25.15%-6.67M	54.13%-1.29M	-99.01%874K	-883.09%-93.28M
End cash Position	7.27%49.26M	7.27%49.26M	4.35%54.88M	97.33%106.33M	5.46%55.9M	-68.61%45.92M	-68.61%45.92M	-66.11%52.59M	-65.90%53.88M	-24.18%53.01M
Free cash flow	34.35%-56.18M	31.76%-12.18M	69.83%-13.36M	-46.50%-13.81M	-20.02%-16.83M	-183.65%-85.57M	-100.24%-17.85M	-460.08%-44.27M	-143.47%-9.43M	-47.98%-14.02M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall